Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Lucio Crinò
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Geographic Areas
Physiology
Sign-in to see full Profile
Network (preview)
24
Tonato, Maurizio
20
Cappuzzo, Federico
15
De Marinis, Filippo
15
Scagliotti, Giorgio
14
Bartolini, Stefania
13
Calandri, Cesare
10
Novello, Silvia
9
Mosconi, Anna Maria
9
Darwish, Samir
8
Rinaldi, Massimo
8
Franceschi, Enrico
7
Gregorc, Vanesa
7
Minotti, Vincenzo
6
Maranzano, Ernesto
6
Ludovini, Vienna
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Lucio Crinò (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Novello Silvia; Falcone Alfredo; Crinò Lucio; Rinaldi Massimo; Nardi Mario; De Marinis Filippo; Tonato Maurizio; Tibaldi Carmelo; Tinazzi Angelo; Russo Francesca; Grassivaro Nicoletta; Scagliotti Giorgio Vittorio
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(3):327-32.
-
2009: Tiseo Marcello; Gridelli Cesare; Cascinu Stefano; Crinò Lucio; Piantedosi Franco Vito; Grossi Francesco; Brandes Alba A; Labianca Roberto; Siena Salvatore; Amoroso Domenico; Belvedere Ornella; Valentino Brunello; Bearz Alessandra; Venturino Paola; Ardizzoni Andrea
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
Lung cancer (Amsterdam, Netherlands) 2009;64(2):199-206.
-
2009: Antognelli Cinzia; Del Buono Chiara; Ludovini Vienna; Gori Stefania; Talesa Vincenzo N; Crinò Lucio; Barberini Francesco; Rulli Antonio
CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
BMC cancer 2009;9():115.
-
2008: Crinò Lucio; Cappuzzo Federico; Zatloukal Petr; Reck Martin; Pesek Milos; Thompson Joyce C; Ford Hugo E R; Hirsch Fred R; Varella-Garcia Marileila; Ghiorghiu Serban; Duffield Emma L; Armour Alison A; Speake Georgina; Cullen Michael
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4253-60.
-
2008: Ludovini Vienna; Pistola Lorenza; Gregorc Vanesa; Floriani Irene; Rulli Eliana; Di Carlo Luciana; Semeraro Antonia; Daddi Giuliano; Darwish Samir; Stocchi Lucia; Tofanetti Francesca Romana; Bellezza Guido; Sidoni Angelo; Tognellini Rita; Crinò Lucio; Tonato Maurizio
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
Tumori 2008;94(3):398-405.
-
2008: Ludovini V; Gori S; Colozza M; Pistola L; Rulli E; Floriani I; Pacifico E; Tofanetti F R; Sidoni A; Basurto C; Rulli A; Crinò L
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):883-90.
-
2008: Ludovini Vienna; Gori Stefania; Pistola Lorenza; Della Fazia Maria Agnese; Piobbico Danilo; Servillo Giuseppe; Flacco Antonella; Scuderi Cristina; Crinò Lucio
Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):452-3.
-
2008: Ludovini Vienna; Pistola Lorenza; Gregorc Vanesa; Floriani Irene; Rulli Eliana; Piattoni Simonetta; Di Carlo Luciana; Semeraro Antonia; Darwish Samir; Tofanetti Francesca Romana; Stocchi Lucia; Mihaylova Zhasmina; Bellezza Guido; Del Sordo Rachele; Daddi Giuliano; Crinò Lucio; Tonato Maurizio
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):365-73.
-
2007: Gori Stefania; Rimondini Simonetta; De Angelis Verena; Colozza Mariantonietta; Bisagni Giancarlo; Moretti Gabriella; Sidoni Angelo; Basurto Carlo; Aristei Cynthia; Anastasi Paola; Crinò Lucio
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
The oncologist 2007;12(7):766-73.
-
2007: Bracarda S; Caserta C; Sordini L; Rossi M; Hamzay A; Crinò L
Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi22-5.
-
2007: Falcone Alfredo; Ricci Sergio; Brunetti Isa; Pfanner Elisabetta; Allegrini Giacomo; Barbara Cecilia; Crinò Lucio; Benedetti Giovanni; Evangelista Walter; Fanchini Laura; Cortesi Enrico; Picone Vincenzo; Vitello Stefano; Chiara Silvana; Granetto Cristina; Porcile Gianfranco; Fioretto Luisa; Orlandini Cinzia; Andreuccetti Michele; Masi Gianluca;
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1670-6.
-
2007: Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti G V
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):903-8.
-
2007: Franceschi E; Cavallo G; Lonardi S; Magrini E; Tosoni A; Grosso D; Scopece L; Blatt V; Urbini B; Pession A; Tallini G; Crinò L; Brandes A A
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
British journal of cancer 2007;96(7):1047-51.
-
2006: Brandes A A; Tosoni A; Cavallo G; Bertorelle R; Gioia V; Franceschi E; Biscuola M; Blatt V; Crinò L; Ermani M;
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).
British journal of cancer 2006;95(9):1155-60.
-
2006: Benedetti Giovanni; Rastelli Francesca; Fedele Massimo; Castellucci Paolo; Damiani Stefania; Crinò Lucio
Presentation of nonseminomatous germ cell tumor of the testis with symptomatic solitary bone metastasis. A case report with review of the literature.
Tumori 2006;92(5):433-6.
-
2006: Scopece Luciano; Franceschi Enrico; Cavallo Giovanna; Paioli Anna; Paioli Gabriele; Conforti Rosa; Palmerini Emanuela; Berzioli Carlotta; Spagnolli Federica; Esposti Roberta Degli; Crinò Lucio
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Journal of neuro-oncology 2006;79(3):299-305.
-
2006: Gori Stefania; Rulli Antonio; Mosconi Anna Maria; Sidoni Angelo; Colozza Mariantonietta; Crinò Lucio
Safety of epirubicin adjuvant chemotherapy in a breast cancer patient with chronic renal failure undergoing hemodialytic treatment.
Tumori 2006;92(4):364-5.
-
2006: Scartozzi Mario; Franciosi Vittorio; Campanini Nicoletta; Benedetti Giovanni; Barbieri Fausto; Rossi Giulio; Berardi Rossana; Camisa Roberta; Silva Rosa Rita; Santinelli Alfredo; Ardizzoni Andrea; Crinò Lucio; Rindi Guido; Cascinu Stefano
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):103-9.
-
2006: Cappuzzo F; Novello S; De Marinis F; Selvaggi G; Scagliotti G V; Barbieri F; Maur M; Papi M; Pasquini E; Bartolini S; Marini L; Crinò L
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2006;52(3):319-25.
-
2006: Metro G; Cappuzzo F; Finocchiaro G; Toschi L; Crinò L
Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v37-46.
-
2006: De Petris L; Crinò L; Scagliotti G V; Gridelli C; Galetta D; Metro G; Novello S; Maione P; Colucci G; de Marinis F
Treatment of advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii36-41.
-
2005: Cappuzzo Federico; Finocchiaro Giovanna; Trisolini Rocco; Toschi Luca; Bartolini Stefania; Metro Giulio; Crinò Lucio
Perspectives on salvage therapy for non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2005;19(8):989-95; discussion 995-6, 999, 1003-4, passim.
-
2005: Franceschi Enrico; Cavallo Giovanna; Scopece Luciano; Esposti Roberta Degli; Paioli Gabriele; Paioli Anna; Palmerini Emanuela; Foschini Maria Pia; Marliani Anna Federica; Crinò Lucio
Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis.
Journal of neuro-oncology 2005;73(3):261-4.
-
2005: Cappuzzo F; Novello S; De Marinis F; Franciosi V; Maur M; Ceribelli A; Lorusso V; Barbieri F; Castaldini L; Crucitta E; Marini L; Bartolini S; Scagliotti G V; Crinò L
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
British journal of cancer 2005;93(1):29-34.
-
2005: Novello S; Kielhorn A; Stynes G; Selvaggi G; De Marinis F; Maestri A; Foggi P; Tilden D; Tonato M; Crinò L; Rinaldi M; Migliorino A M; Scagliotti G V;
Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.
Lung cancer (Amsterdam, Netherlands) 2005;48(3):379-87.
-
2005: Maestri Antonio; De Pasquale Ceratti Adolfo; Cundari Sante; Zanna Claudio; Cortesi Enrico; Crinò Lucio
A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy.
Tumori 2005;91(2):135-8.
-
2005: Rastelli Francesca; Benedetti Giovanni; Di Tommaso Luca; Mazzoli Matteo; Calbucci Fabio; Crinò Lucio
Intramedullary spinal metastasis from ovarian cancer.
The lancet oncology 2005;6(2):123-5.
-
2004: Gregorc Vanesa; Ceresoli Giovanni Luca; Floriani Irene; Spreafico Anna; Bencardino Katia Bruna; Ludovini Vienna; Pistola Lorenza; Mihaylova Zhasmina; Tofanetti Francesca Romana; Ferraldeschi Massimiliano; Torri Valter; Cappuzzo Federico; Crinò Lucio; Tonato Maurizio; Villa Eugenio
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6006-12.
-
2004: Benedetti Giovanni; Rastelli Francesca; Damiani Stefania; Calandri Cesare; Crinò Lucio
Challenging problems in malignancy: case 1. Presentation of small-cell lung cancer with marked hyperamylasemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3826-8.
-
2004: Franceschi E; Cavallo G; Scopece L; Paioli A; Pession A; Magrini E; Conforti R; Palmerini E; Bartolini S; Rimondini S; Esposti R Degli; Crinò L
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
British journal of cancer 2004;91(6):1038-44.
-
2004: Cappuzzo Federico; Magrini Elisabetta; Ceresoli Giovanni Luca; Bartolini Stefania; Rossi Elisa; Ludovini Vienna; Gregorc Vanesa; Ligorio Claudia; Cancellieri Alessandra; Damiani Stefania; Spreafico Anna; Paties Carlo Terenzio; Lombardo Laura; Calandri Cesare; Bellezza Guido; Tonato Maurizio; Crinò Lucio
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer.
Journal of the National Cancer Institute 2004;96(15):1133-41.
-
2004: Cappuzzo Federico; Bartolini Stefania; Calandri Cesare; Crinò Lucio
Induction therapy for early-stage non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2004;18(8 Suppl 5):32-7.
-
2004: Ceresoli G L; Cappuzzo F; Gregorc V; Bartolini S; Crinò L; Villa E
Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1042-7.
-
2004: Cappuzzo F; Bartolini S; Ceresoli G L; Tamberi S; Spreafico A; Lombardo L; Gregorc V; Toschi L; Calandri C; Villa E; Crinò L
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).
British journal of cancer 2004;90(1):82-6.
-
2004: Gori S; Colozza M; Mosconi A M; Franceschi E; Basurto C; Cherubini R; Sidoni A; Rulli A; Bisacci C; De Angelis V; Crinò L; Tonato M
Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.
British journal of cancer 2004;90(1):36-40.
-
2004: Cappuzzo F; Mazzoni F; Gennari A; Donati S; Salvadori B; Orlandini C; Cetto G L; Molino A; Galligioni E; Mansutti M; Tumolo S; Lucentini A; Valduga F; Bartolini S; Crinò L; Conte P F
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer.
British journal of cancer 2004;90(1):31-5.
-
2003: Cappuzzo Federico; De Marinis Filippo; Nelli Fabrizio; Calandri Cesare; Maestri Antonio; Benedetti Giovanni; Migliorino Maria Rita; Cortesi Enrico; Rastelli Francesca; Martelli Olga; Andruccetti Michele; Bartolini Stefania; Crinò Lucio
Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42(3):355-61.
-
2003: Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P
Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
Magnetic resonance imaging 2003;21(9):1003-7.
-
2003: Rossi Giulio; Cavazza Alberto; Marchioni Alessandro; Migaldi Mario; Bavieri Mario; Facciolongo Nicola; Petruzzelli Stefano; Longo Lucia; Tamberi Stefano; Crinò Lucio
Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(10):1041-7.
-
2003: Scagliotti Giorgio V; Fossati Roldano; Torri Valter; Crinò Lucio; Giaccone Giuseppe; Silvano Giovanni; Martelli Massimo; Clerici Maurizia; Cognetti Francesco; Tonato Maurizio;
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Journal of the National Cancer Institute 2003;95(19):1453-61.
-
2003: Cappuzzo Federico; Ardizzoni Andrea; Soto-Parra Hector; Gridelli Cesare; Maione Paolo; Tiseo Marcello; Calandri Cesare; Bartolini Stefania; Santoro Armando; Crinò Lucio
Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2003;41(2):227-31.
-
2003: Cappuzzo F; Calandri C; Bartolini S; Crinò L
ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases.
British journal of cancer 2003;89(2):246-7.
-
2003: Cappuzzo Federico; Selvaggi Giovanni; Gregorc Vanesa; Mazzoni Francesca; Betti Maura; Rita Migliorino Maria; Novello Silvia; Maestri Antonio; De Marinis Filippo; Darwish Samir; De Angelis Verena; Nelli Fabrizio; Bartolini Stefania; Scagliotti Giorgio V; Tonato Maurizio; Crinò Lucio
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cancer 2003;98(1):128-34.
-
2003: Rosell Rafael; Scagliotti Giorgio; Danenberg Kathleen D; Lord Reginald V N; Bepler Gerold; Novello Silvia; Cooc Janine; Crinò Lucio; Sánchez José Javier; Taron Miquel; Boni Corrado; De Marinis Filippo; Tonato Maurizio; Marangolo Maurizio; Gozzelino Felice; Di Costanzo Franceso; Rinaldi Massimo; Salonga Dennis; Stephens Craig
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.
Oncogene 2003;22(23):3548-53.
-
2003: Cappuzzo Federico; Bartolini Stefania; Crinò Lucio
Emerging drugs for non-small cell lung cancer.
Expert opinion on emerging drugs 2003;8(1):179-92.
-
2002: Crinò Lucio; Franceschi Enrico; Scopece Luciano
HER-2 inhibitors: clinical results.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(6):S3-4.
-
2002: Crinò Lucio; Calandri Cesare
Gemzar platinum combinations: phase III trials in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 2():S9-12.
-
2002: Scagliotti G V; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Matano E; Boni C; Marangolo M; Failla G; Altavilla G; Adamo V; Ceribelli A; Clerici M; Di Costanzo F; Frontini L; Tonato M;
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4285-91.
-
2002: Crinò L
New cytotoxics.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):S41-2.
-
2002: Crinò Lucio; Cappuzzo Federico
New platinum derivatives in advanced non-small cell lung cancer.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S24-5.
-
2002: Maranzano Ernesto; Crinò Lucio; Piro Fabrizio; Meacci Luisa; Bracarda Sergio; de Angelis Verena; Darwish Samir; Minotti Vincenzo; Panizza Bianca Moira; de Marinis Filippo; Latini Paolo; Tonato Maurizio
Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):79-85.
-
2002: Crinò Lucio; Cappuzzo Federico
Present and future treatment of advanced non-small cell lung cancer.
Seminars in oncology 2002;29(3 Suppl 9):9-16.
-
2002: Crinò Lucio; Cappuzzo Federico
Gemcitabine in non-small cell lung cancer.
Expert opinion on pharmacotherapy 2002;3(6):745-53.
-
2001: Crinò L; Cappuzzo F
Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 3():S45-7.
-
2001: Crinò L; Mosconi A M; Calandri C; Corgna E; Porrozzi S; Chiara S; Nobili M T; Tonato M
Gemcitabine in advanced pancreatic cancer: a phase II trial.
American journal of clinical oncology 2001;24(3):296-8.
-
2001: Crinò L; Calandri C; Maestri A; Marrocolo F
Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2001;15(3 Suppl 6):40-2.
-
2000: Rinaldi M; Crinò L; Scagliotti G V; Mosconi A M; De Marinis F; Gridelli C; Selvaggi G; Della Giulia M; Darwish S; Porrozzi S; Novello S; Cipri A; Bartolucci R; Calandri C; Tonato M
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1295-300.
-
1999: Crinò L; Scagliotti G V; Ricci S; De Marinis F; Rinaldi M; Gridelli C; Ceribelli A; Bianco R; Marangolo M; Di Costanzo F; Sassi M; Barni S; Ravaioli A; Adamo V; Portalone L; Cruciani G; Masotti A; Ferrara G; Gozzelino F; Tonato M
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3522-30.
-
1999: Crinò L; Mosconi A M; Scagliotti G; Selvaggi G; Novello S; Rinaldi M; Della Giulia M; Gridelli C; Rossi A; Calandri C; De Marinis F; Noseda M; Tonato M
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2081-5.
-
1998: Boni C; Savoldi L; Bisagni G; Ceci G; Crinò L; De Lisi V; Di Costanzo F; Lasagni L; Manenti A L; Moretti G; Rondini E; Sassi M; Zadro A
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC).
European journal of cancer (Oxford, England : 1990) 1998;34(12):1974-6.
-
1998: Crinò L; Mosconi A M; Scagliotti G V; Selvaggi G; Rinaldi M; Della Giulia M; Gridelli C; Calandri C; De Marinis F; Noseda M; Tonato M
Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.
Seminars in oncology 1998;25(4 Suppl 9):23-6.
-
1998: Minotti V; Crinò L; Meacci M L; Corgna E; Darwish S; Palladino M A; Betti M; Tonato M
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;20(2):93-8.
-
1997: Crinò L; Corgna E; Porrozzi S; Palladino M A; Darwish S; Minotti V; Mosconi A M; Tonato M
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):709-11.
-
1997: Scagliotti G V; Crinò L
Chemotherapy of non-small cell lung cancer.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1997;52(3):287-95.
-
1997: Mosconi A M; Crinò L; Tonato M
Combination therapy with gemcitabine in non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1997;33 Suppl 1():S14-7.
-
1997: Crinò L; Scagliotti G; Marangolo M; Figoli F; Clerici M; De Marinis F; Salvati F; Cruciani G; Dogliotti L; Pucci F; Paccagnella A; Adamo V; Altavilla G; Incoronato P; Trippetti M; Mosconi A M; Santucci A; Sorbolini S; Oliva C; Tonato M
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):297-303.
-
1995: Crinò L; Clerici M; Figoli F; Carlini P; Ceci G; Cortesi E; Carpi A; Santini A; Di Costanzo F; Boni C
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(4):347-53.
-
1995: Darwish S; Minotti V; Crinò L; Rossetti R; Fiaschini P; Maranzano E; Checcaglini F; Todisco T; Giansanti M; Mercati U
A phase II trial of combined chemotherapy and surgery in stage IIIA non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S71-8.
-
1995: Crinò L; Clerici M; Figoli F; Barduagni M; Carlini P; Ceci G; Cortesi E; Carpi A; Santini A; Di Costanzo F
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S125-32.
-
1995: Crinò L
Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6 Suppl 3():S45-7.
-
1994: Darwish S; Minotti V; Crinò L; Rossetti R; Maranzano E; Checcaglini F; Fiaschini P; Mercati U; Penza O; Vitali R
Neoadjuvant cisplatin and etoposide for stage IIIA (clinical N2) non-small cell lung cancer.
American journal of clinical oncology 1994;17(1):64-7.
-
1994: Crinò L; Meacci M; Tonato M
Italian clinical experience from the major co-operative groups in small cell lung cancer.
Anticancer research 1994;14(1B):321-5.
-
1993: Crinò L; Latini P; Meacci M; Corgna E; Maranzano E; Darwish S; Minotti V; Santucci A; Tonato M
Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):847-51.
-
1991: Mercati U; Fiaschini P; Darwish S; Minotti V; Crinò L; Tonato M; Maranzano E; Checcaglini F; Meacci M; Cavaliere A
[Surgery after neo-adjuvant therapy of non-small cell lung cancer. Preliminary results]
Minerva chirurgica 1991;46(17):879-84.
-
1987: Latini P; Maranzano E; Checcaglini F; Tonato M; Crinò L; Panizza B M; Aristei C
[Combined chemotherapeutic and radiotherapeutic treatment of limited pulmonary microcytoma]
La Radiologia medica 1987;73(6):539-44.
Sign-in to see more
